ATyr Pharma (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "ATyr Pharma" in English language version.

refsWebsite

Global rank English rank

99^th place

77^th place

low place

6,978^th place

4^th place

4^th place

2,740^th place

2,050^th place

1clinicaltrials.gov

5,225^th place

4,062^nd place

low place

low place

1fiercebiotech.com

low place

8,828^th place

low place

low place

1redherring.com

low place

low place

1atyrpharma.com

low place

low place

low place

low place

2^nd place

2^nd place

atyrpharma.com

investors.atyrpharma.com

aTyr Pharma news release: aTyr Pharma, Inc. Announces Closing of Initial Public Offering (May 12, 2015)

bloomberg.com

Bloomberg: Company Overview of aTyr Pharma, Inc.
"Company Overview of aTyr Pharma, Inc". www.bloomberg.com.

clinicaltrials.gov

"Study of Intravenous ATYR1923 for Pulmonary Sarcoidosis". 27 June 2023.

doi.org

Guo, M; Schimmel, P (March 2013). "Essential nontranslational functions of tRNA synthetases". Nat Chem Biol. 9 (3): 145–153. doi:10.1038/nchembio.1158. PMC 3773598. PMID 23416400.

fiercebiotech.com

FierceBiotech: Domain leads $23M round for aTyr Pharma (Oct. 26, 2010)

nasdaq.com

secfilings.nasdaq.com

"aTYR PHARMA INC (Form: 10-K, Received: 03/30/2016 16:28:57)". secfilings.nasdaq.com.

nih.gov

ncbi.nlm.nih.gov

Guo, M; Schimmel, P (March 2013). "Essential nontranslational functions of tRNA synthetases". Nat Chem Biol. 9 (3): 145–153. doi:10.1038/nchembio.1158. PMC 3773598. PMID 23416400.

pubmed.ncbi.nlm.nih.gov

Guo, M; Schimmel, P (March 2013). "Essential nontranslational functions of tRNA synthetases". Nat Chem Biol. 9 (3): 145–153. doi:10.1038/nchembio.1158. PMC 3773598. PMID 23416400.

redherring.com

Red Herring: 2011 Top 100 North America

sdbj.com

San Diego Business Journal: aTyr Pharma Inc. Secures $59M In Funding (July 30, 2013)

sddt.com

San Diego Daily Transcript: aTyr Pharma closes $10.5 million Series B financing (April 18, 2007)

sec.report

SEC: SEC S-1 Funds (Jan. 17, 2020)

xconomy.com

Xconomy: ATyr Pharma Raises $76M Round to Advance Physiocrine Drugs by Bruce Bigelow (April 1, 2015)
Xconomy: After raising $76M in Series E Round, aTyr Pharma Files for IPO by Bruce Bigelow (April 7, 2015)